Michelle Veiga de Almeida

Michelle Veiga de Almeida

Auto-generated profile, based on publicly available information

Michelle Veiga de Almeida

Universidade Federal de Mato Grosso, Brazil

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Revista da Escola de Enfermagem da USP
Verified
Journal Article
Open access
RBRaissa Mariah Ferraz Moreira Barcelos
Raissa Mariah Ferraz Moreira Barcelos
GSGutembergue Santos de Sousa
Gutembergue Santos de Sousa
MAMichelle Veiga de Almeida
Michelle Veiga de Almeida
FPFabiana Gulin Longhi Palacio
Fabiana Gulin Longhi Palacio
MGMaria Aparecida Munhoz Gaíva
Maria Aparecida Munhoz Gaíva
SFSilvana Margarida Benevides Ferreira
Silvana Margarida Benevides Ferreira
Objective: To explore the scientific evidence regarding the leprosy patients quality of life. Method: Scoping review according to the Joanna Briggs Institute methodology, with articles indexed in PubMed, Cochrane, LILACS, Embase, CINAHL, Scopus, Web of Science, PsyINFO, INFOLEP, and Google Scholar databases, published in full in Portuguese, English, or Spanish. Results: Seventy-four studies were identified, with 71 of quantitative approach and 3 with a mixed method. There was a predominance of studies published in Brazil (58.1%), with an adult population, (97.3%) and recruited in reference centers for the treatment of leprosy (52.7%). There was greater use of the WHOQOL-bref (50%) and SF-36 (18.9%) instruments to assess quality of life. The study showed that the greatest impairment in quality of life was related to the delay in the diagnosis of the disease, to leprosy reactions, physical disabilities, neuropathic pain, and stigma. Conclusion: Most studies were developed in endemic countries, with adults, and based on observational studies, and the worst scores obtained were associated with physical domain impairment.